Año 2019 / Volumen 111 / Número 1
Original
Apparent diffusion coefficient and enhancement patterns in MR imaging as markers of severe or moderate ileum inflammation in Crohn’s disease

28-33

DOI: 10.17235/reed.2018.5691/2018

Riccardo Faletti, Davide Giuseppe Ribaldone, Marco Gatti, Chiara Perazzini, Mattia Robella, Francesca Angelino, Giorgio Maria Saracco, Marco Astegiano, Rinaldo Pellicano, Paolo Fonio,

Resumen
Background and purpose: magnetic resonance enterography has been increasingly used for the diagnosis and follow-up of Crohn’s disease (CD). The purpose of the study was to compare the apparent diffusion coefficient (ADC) with wall enhancement for the differentiation of severe, moderate or no inflammation activity in the ileum. Methods: a prospective, blinded study was conducted of 46 CD patients with a clinical Crohn’s disease activity index (CDAI) ≥ 220 and a simple endoscopic score for Crohn’s disease (ES-CD) ≥ 7, which yielded 58 inflamed segments with CD. Twenty controls were also included. All segments were characterized by four ADC readings. The two different enhancement patterns observed in inflamed segments, transmural or mucosal, were associated with severely (23) or moderately (35) active CD. Results: the ADC value decreased from 2.79 ± 0.35 x 10-3 mm2/s for normal segments to 1.81 ± 0.39 x 10-3 mm2/s for the moderately inflamed segments and 1.15 ± 0.20 x 10-3 mm2/s for severely inflamed segments (p ≤ 0.0001). ROC curve analysis on the basis of the three ADC distributions showed a very good discrimination capability with an area under the curve of 0.95. Three groups were defined as follows: normal ileum ADC > 2.4 x 10-3 mm2/s, moderate stages of inflammation 1.5 x 10-3 mm2/s < ADC ≤ 2.4 x 10-3 mm2/s and severe stages of ADC ≤ 1.5 x 10-3 mm2/s. Conclusions: the ADC value reliably discriminates between normal and inflamed ileum and also distinguishes between severe and moderate inflammation.
Share Button
Nuevo comentario
Comentarios
No hay comentarios para este artículo.
Bibliografía
1. Kiryu S, Dodanuki K, Takao H, et al. Free-Breathing Diffusion-Weighted Imaging for the Assessment of Inflammatory Activity in Crohn’s Disease. J Magnetic Reson Imaging 2009; 29: 880-6.
2. Griffin N, Grant LA, Anderson S, et al. Small bowel MR enterography: problem solving in Crohn's disease. Insight imaging 2012; 3: 251-63.
3. Del Vescovo R, Sansoni I, Caviglia R, et al. Dynamic contrast enhanced magnetic resonance imaging of the terminal ileum: differentiation of activity of Crohn's disease. Abdom Imaging 2008; 33: 417-24.
4. Makanyanga J, Punwani S, Taylor SA. Assessment of wall inflammation and fibrosis in Crohn’s disease: value of T1-weighted gadolinium-enhanced MR imaging. Abdom Imaging 2012; 37: 933-43.
5. Sinha R, Verma R, Verma S, et al. MR Enterography of Crohn Disease: Part 2, Imaging and Pathologic Findings. AJR 2011; 197: 80-85.
6. Tielbeek JA, Ziech ML, Li Z, et al. Evaluation of conventional, dynamic contrast enhanced and diffusion weighted MRI for quantitative Crohn's disease assessment with histopathology of surgical specimens. Eur Radiol 2014; 24:619629.
7. Oto A, Zhu F, Kulkarni K, et al. Evaluation of Diffusion-weighted MR Imaging for Detection of Bowel Inflammation in Patients with Crohn’s Disease. Acad Radiology 2009; 16: 597-603.
11. Caruso A, DʼIncà R, Scarpa M, et al. Diffusion-weighted magnetic resonance for assessing ileal Crohn's disease activity. Inflamm Bowel Dis 2014; 20: 1575-83.
8. Foti PV, Farina R, Coronella M, et al. Crohn's disease of the small bowel: evaluation of ileal inflammation by diffusion-weighted MR imaging and correlation with the Harvey-Bradshaw index. Radiol Med 2015; 120: 585-94.
9. Hordonneau C, Buisson A, Scanzi J, et al. Diffusion-weighted magnetic resonance imaging in ileocolonic Crohn's disease: validation of quantitative index of activity. Am J Gastroenterol 2014; 109:89-98.
10. Oto A, Kayhan A, Williams JT, et al. Active Crohn’s Disease in the Small Bowel: Evaluation by Diffusion Weighted Imaging and Quantitative Dynamic Contrast Enhanced MR Imaging. J Magn Reson Imaging 2011; 33: 615-24.
12. Gomollón F, Dignass A, Annese V, et al. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management. J Crohns Colitis 2017; 11: 3-25.
13. Seo N, Park SH, Kim K-J, Kang B-K, Lee Y, Yang S-K, et al. MR Enterography for the Evaluation of Small-Bowel Inflammation in Crohn Disease by Using Diffusion-weighted Imaging without Intravenous Contrast Material: A Prospective Noninferiority Study. Radiology 2016;278(3):762–72.
Artículos relacionados

Imagen en Patología Digestiva

Intestinal and perianal tuberculosis: an uncommon clinical presentation and challenging diagnosis

DOI: 10.17235/reed.2022.8988/2022

Imagen en Patología Digestiva

Enfermedad de Crohn cutánea periostomal por contigüidad

DOI: 10.17235/reed.2022.8909/2022

Original

Mercaptopurine and inflammatory bowel disease: the other thiopurine

DOI: 10.17235/reed.2016.4546/2016

Carta al Editor

Adnexal localization of Crohn’s disease and recurrent massive ovary cysts

DOI: 10.17235/reed.2016.4301/2016

Caso Clínico

Enfermedad de Crohn metastásica en pediatría

DOI: 10.17235/reed.2016.3948/2015

Carta al Editor

Debut conjunto de enfermedad de Crohn y síndrome de Sweet

DOI: 10.17235/reed.2015.3842/2015

Caso Clínico

Afectación ovárica en la enfermedad de Crohn: una complicación rara

DOI: 10.17235/reed.2015.3764/2015

Instrucciones para citar
Faletti R, Ribaldone D, Gatti M, Perazzini C, Robella M, Angelino F, et all. Apparent diffusion coefficient and enhancement patterns in MR imaging as markers of severe or moderate ileum inflammation in Crohn’s disease. 5691/2018


Descargar en un gestor de citas

Descargue la cita de este artículo haciendo clic en uno de los siguientes gestores de citas:

Métrica
Este artículo ha sido visitado 914 veces.
Este artículo ha sido descargado 119 veces.

Estadísticas de Dimensions


Estadísticas de Plum Analytics

Ficha Técnica

Recibido: 02/05/2018

Aceptado: 13/07/2018

Prepublicado: 04/10/2018

Publicado: 17/01/2019

Tiempo de revisión del artículo: 69 días

Tiempo de prepublicación: 155 días

Tiempo de edición del artículo: 260 días


Compartir
Este artículo ha sido valorado por 1 lectores .
Valoración del lector:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
La REED es el órgano oficial de la Sociedad Española de Patología Digestiva, la SociedadEspañola de Endoscopia Digestiva y la Asociación Española de Ecografía Digestiva
Política de cookies Política de Privacidad Aviso Legal © Copyright 2023 y Creative Commons. Revista Española de Enfermedades Digestivas